The Impella® devices are minimally invasive catheter pumps that can support the heart with up to 5.5 liters of blood per minute. The pumps can be implanted percutaneously, via a cut-down, or in the OR. The Impella® Mobile Console facilitates patient transport in-house and to other hospitals for additional care. In Europe, ABIOMED offers the Impella® minimally invasive cardiovascular support systems under CE Mark approval.

Peripherally Introduced Impellas Surgical Impellas

Picture from left to right: Impella® LP2.5, LP5.0, LD, (one Euro coin for size comparison), RD

Peripherally Introduced Impellas

The Impella® LP2.5 is an active left ventricular unloading catheter that is implanted percutaneously, supporting and stabilizing the heart in critical situations. It has been used in European centers to support patients during high-risk PCI, post PCI, AMI and cardiogenic shock. It can be used for up to 5 days.

Impella® LP5.0 is an intracardiac blood pump that is inserted via a cut-down in the femoral artery. As a ventricular unloading catheter, the Impella® LP5.0 supports the hemodynamically comprised myocardium with up to 5.0 liters of blood per minute for up to 10 days.

Surgical Impellas

Impella® LD is the smallest available left ventricular unloading device. Once surgically placed, it actively unloads the left ventricle, pumping up to 5 liters of blood per minute, supporting the heart for up to 10 days.

Impella® RD represents the smallest available fully implantable, right ventricular unloading technology, weighing only 17 grams. Due to its small size and the outstanding design, the pump is easy to implant. The Impella® RD can deliver up to 5.5 liters of blood per minute from the right atrium via the outlet graft into the pulmonary artery, allowing the heart to rest and recover. It can also be used up to 10 days.